» Articles » PMID: 32914221

Toxoplasma Invasion Delayed by TgERK7 Eradication

Overview
Journal Parasitol Res
Specialty Parasitology
Date 2020 Sep 11
PMID 32914221
Authors
Affiliations
Soon will be listed here.
Abstract

Toxoplasma gondii causes serious clinical toxoplasmosis in humans mostly due to its asexual life cycles, which can be artificially divided into five tightly coterminous stages. Any radical or delay for the stage will result in tremendous changes immediately behind. We previously demonstrated that TgERK7 is associated with the intracellular proliferation of T. gondii, but during the process, other stages before were not meanwhile determined. To further clarify the function of ERK7 gene in T. gondii, the complemental strain of ΔTgERK7 tachyzoites created previously was engineered via electric transfection with the recombinant pUC/Tgerk7 plasmid, named pUC/TgERK7 strain in this study, and was used together with ΔTgERK7 and wild-type GT1 strains to retrospect the phenotypic changes including invasion and attachment. The results showed that TgERK7 protein can be re-expressed in the ΔTgERK7 tachyzoites and eradication of this protein leads to significantly lower invasion of T. gondii at 1 h and 2 h post-infection (P < 0.05), which is the key factor causing the following slow intracellular proliferation, in comparison with wild-type GT1 and pUC/TgERK7 parasites; noteworthily, at other early time points including 15 min for attachment assay was no statistical difference (P > 0.05). The data suggested that ERK7 protein in T. gondii is an important virulence factor that participates in the invasion of this parasite.

References
1.
An R, Tang Y, Chen L, Cai H, Lai D, Liu K . Encephalitis is mediated by ROP18 of , a severe pathogen in AIDS patients. Proc Natl Acad Sci U S A. 2018; 115(23):E5344-E5352. PMC: 6003310. DOI: 10.1073/pnas.1801118115. View

2.
Blader I, Coleman B, Chen C, Gubbels M . Lytic Cycle of Toxoplasma gondii: 15 Years Later. Annu Rev Microbiol. 2015; 69:463-85. PMC: 4659696. DOI: 10.1146/annurev-micro-091014-104100. View

3.
Dard C, Marty P, Brenier-Pinchart M, Garnaud C, Fricker-Hidalgo H, Pelloux H . Management of toxoplasmosis in transplant recipients: an update. Expert Rev Anti Infect Ther. 2018; 16(6):447-460. DOI: 10.1080/14787210.2018.1483721. View

4.
Ghosh S, Chisholm S, Dans M, Lakkavaram A, Kennedy K, Ralph S . The cysteine protease dipeptidyl aminopeptidase 3 does not contribute to egress of Plasmodium falciparum from host red blood cells. PLoS One. 2018; 13(3):e0193538. PMC: 5839547. DOI: 10.1371/journal.pone.0193538. View

5.
Guo H, Li Z, Wang J, Geng Z, Zhu X . Immune Responses Induced by pVAX/ERK7 against Infection in BALB/c Mice. Iran J Parasitol. 2020; 14(4):552-562. PMC: 7028233. View